- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1776-260X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Precision Oncology for Cancer Immunotherapies in Early-Phase Clinical Trials ; volume:14 ; number:6 ; day:8 ; month:10 ; year:2019 ; pages:631-637 ; date:12.2019
Targeted oncology ; 14, Heft 6 (8.10.2019), 631-637, 12.2019
- Creator
-
Paliard, Xavier
Rixe, Olivier
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11523-019-00678-w
- URN
-
urn:nbn:de:101:1-2020032017515091912004
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-14T10:59:50+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Paliard, Xavier
- Rixe, Olivier
- SpringerLink (Online service)
Other Objects (12)
Phase I Clinical Trials in Oncology
Harnessing bioengineered myeloid progenitors for precision immunotherapies
Evolving or immutable - phase I solid tumor trials in the era of precision oncology
Bias and precision in early phase adaptive oncology studies and its consequences for confirmatory trials
Quo vadis precision oncology?
Clinical trials in oncology
Precision medicine in pediatric oncology
Flexible designs for single-arm phase II trials in oncology
Phase I dose-escalation oncology trials with sequential multiple schedules
Design considerations for early-phase clinical trials of immune-oncology agents
Optimal Adaptive Designs for Early Phase II Trials in Clinical Oncology
npj precision oncology : a natureresearch journal
Phase I Clinical Trials in Oncology
Harnessing bioengineered myeloid progenitors for precision immunotherapies
Evolving or immutable - phase I solid tumor trials in the era of precision oncology
Bias and precision in early phase adaptive oncology studies and its consequences for confirmatory trials
Quo vadis precision oncology?
Clinical trials in oncology
Precision medicine in pediatric oncology
Flexible designs for single-arm phase II trials in oncology
Phase I dose-escalation oncology trials with sequential multiple schedules
Design considerations for early-phase clinical trials of immune-oncology agents
Optimal Adaptive Designs for Early Phase II Trials in Clinical Oncology
npj precision oncology : a natureresearch journal
Phase I Clinical Trials in Oncology
Harnessing bioengineered myeloid progenitors for precision immunotherapies
Evolving or immutable - phase I solid tumor trials in the era of precision oncology
Bias and precision in early phase adaptive oncology studies and its consequences for confirmatory trials
Quo vadis precision oncology?
Clinical trials in oncology
Precision medicine in pediatric oncology
Flexible designs for single-arm phase II trials in oncology
Phase I dose-escalation oncology trials with sequential multiple schedules
Design considerations for early-phase clinical trials of immune-oncology agents
Optimal Adaptive Designs for Early Phase II Trials in Clinical Oncology